After the approval by the WHO, Shanchol may be kept for a single period of time at temperature of up to 40C for up to 14 days immediately prior to administration.
The approval is of great significance to regions where the vaccine is used, including India, as it eliminates the challenges of maintaining the vaccine cold chain during transport, Sanofi Pasteur said in a statement.
Shantha Biotechnics' Executive Director and COO Mahesh Bhalgat said : "This is a significant milestone in our efforts towards effective cholera prevention and control."
The WHO approval for use of Shanchol in controlled temperature chain was granted after a review of its stability data, the statement said.
More From This Section
"This important development will make it easier to deliver vaccines to the remote areas where it is desperately needed, saving lives and contributing to the global effort to finally consign this disease to the history books," said Anuradha Gupta, Deputy CEO of Gavi, the Vaccine Alliance.
Cholera is caused by a bacterium, vibrio cholerae, which produces a toxin that affects the intestines.